Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) research hub

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

This study is testing a new medicine, remibrutinib, for chronic urticaria, also known as chronic hives. We want to see how well it works and how safe it is for people whose hives haven't improved with other treatments.